HBV reactivation in HCC patients following TACE: risk factors, antiviral therapy impact, and survival analysis. - Zhang H; Du JH; Lu ZY; Wu DD; Ma L; Yang JY; Huang YH; Zhang YQ (Frontiers in oncology, 2026)